PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Oct-2021 Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million Businesswire
14-Oct-2021 Global Peptide Therapeutics Marketplace 2021-2026: Key Applications, Drug Types, Types of Manufacturing, Synthesis Technologies, Regions & Players - ResearchAndMarkets.com Businesswire
14-Oct-2021 Global Home Healthcare Market Analysis 2021-2026 with Profiles of Major Players Fresenius, GE Healthcare, Linde, Roche, and More - ResearchAndMarkets.com Businesswire
14-Oct-2021 Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical Newswire
14-Oct-2021 Kyowa Kirin International: New Real World Evidence Underlines Benefits of POTELIGEO®▼ (mogamulizumab) Treatment for Cutaneous T-cell Lymphoma (CTCL) Patients Businesswire
14-Oct-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Oct-2021 New Four-year Data Show Sustained Relapse Reduction by Chugai’s Enspryng in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) Businesswire
14-Oct-2021 Connext Asia: Körber brings pharma MES users in Asia-Pacific together virtually Körber
14-Oct-2021 Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China Businesswire
14-Oct-2021 Adocia annonce que son partenaire Tonghua Dongbao a reçu l'autorisation de commencer le programme de Phase 3 de l'insuline ultra-rapide BioChaperone® Lispro pour le traitement des diabètes de type 1 et 2 en Chine Businesswire
14-Oct-2021 New 4-Year Data Show Genentech’s Enspryng (satralizumab-mwge) Significantly Reduces Debilitating Relapses in People With Neuromyelitis Optica Spectrum Disorder Businesswire
13-Oct-2021 Pearl to Introduce Groundbreaking AI to Australian and New Zealand Dentistry Businesswire
13-Oct-2021 Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call Businesswire
13-Oct-2021 FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, as Treatment for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS ≥1) Businesswire
13-Oct-2021 Nouvelles données relatives à l'innocuité du traitement par COPAXONE® (acétate de glatiramère) chez des mères allaitantes atteintes de sclérose en plaques cyclique Businesswire
13-Oct-2021 Global $38.79 Bn Companion Diagnostic Markets to 2026 with Focus on Kits and Reagents, Assays, Software, and Services - ResearchAndMarkets.com Businesswire
13-Oct-2021 Global High Performance Alloys Market Trajectory & Analytics, 2021-2026 - ResearchAndMarkets.com Businesswire
13-Oct-2021 Genomic Vision Strengthens Its Leadership Team With the Appointment of Thierry HUET as R&D Director Businesswire
13-Oct-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nano-X Imaging Ltd. (NNOX) on Behalf of Investors Businesswire
13-Oct-2021 AmeriHealth Caritas Appoints Mark Grippi Market President of its Ohio Medicaid Plan Businesswire